RAM
RVMD icon

Readystate Asset Management’s Revolution Medicines RVMD Stock Holding History

Readystate Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.07M Buy
37,727
+5,880
+18% +$859K 0.24% 95
2026
Q1 		$3.1M Buy
+31,847
New +$3.22M 0.14% 107
2024
Q3 		– Sell
-163,241
Closed -$6.34M – 782
2024
Q2 		$6.34M Buy
163,241
+95,941
+143% +$3.59M 0.21% 87
2024
Q1 		$2.17M Buy
+67,300
New +$1.99M 0.03% 542

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Readystate Asset Management's RVMD Position: Q2 2026 in Review

Readystate Asset Management increased its Revolution Medicines (RVMD) stake by 18% in Q2 2026, buying an estimated $859K and bringing the position to 37,727 shares worth $7.07M. The position accounts for 0.24% of the portfolio, ranked #95.

Readystate Asset Management first reported a position in RVMD in Q1 2024 and has held it in 4 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Readystate Asset Management held 37,727 shares of Revolution Medicines worth $7.07M as of Q2 2026.
  • Readystate Asset Management bought 5,880 Revolution Medicines shares in Q2 2026, an estimated $859K.
  • Revolution Medicines made up 0.24% of Readystate Asset Management's portfolio in Q2 2026, its #95 holding.
  • Readystate Asset Management first reported a position in Revolution Medicines in Q1 2024 and has held it in 4 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Readystate Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.